Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05238558
Title Safety and Immune Response to FMPV-1
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Hubro Therapeutics AS
Age Groups: adult | senior
Covered Countries

No variant requirements are available.